Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Neutral
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Weak
Balance Sheet
Strong
Website
Diaceutics Plc
Telephone
Address
Building Two, First Floor, King's Hall Building, Belfast, Antrim BT9 6GW
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 1.12 - 1.8
Trade Value (12mth)
US$66,975.00
1 week
-0.3%
1 month
-3.16%
YTD
31.13%
1 year
20.79%
All time high
1.95
EPS 3 yr Growth
-401.50%
EBITDA Margin
7.20%
Operating Cashflow
£1m
Free Cash Flow Return
3.00%
ROIC
-4.10%
Interest Coverage
43.10
Quick Ratio
3.80
Shares Outstanding (Fully Diluted)
85m
HALO Sector
Healthcare
Next Company Report Date
15-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
GBP
Short Sell (% of issue)
0.00
| Date | Announcements |
| 13 May 26 | |
| 12 May 26 | |
| 05 May 26 | |
| 16 April 26 | |
| 07 April 26 |
Historical data
Forecast data
| GBP | 2020 | 2021 | 2022 | 2023 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | £ |  | | | | 0.01 | -0.02 | -0.02 | | | | ||
EPS (Fully Diluted) | £ | | | | | 0.01 | -0.02 | -0.02 | | | | ||
Growth | % | | | | | 28.4 | -340.7 | 2.4 | | | | ||
PE | X | | | | | 87.8 | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | 13.9 | 28.1 | 40.5 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
